CYP2E1 and glioma: According to a study that demonstrated a negative correlation between CYP2E1 and immune checkpoints, changes in the expression level of CYP2E1 in glioma were related to the immunosuppressive characteristics of the tumor microenvironment (Wang et al., 2019).